CD4 and diabetes mellitus: These mice developed diabetes when injected with polyI:C (Toll-like receptor 3 agonist) and spontaneous diabetes when co-expressing RIP-hB7.1 along with CD8+ and CD4+ T cell responses that largely overlap (41, 42).